US 12,276,869 B1
WS12-releasing contact lens
Erwin Si, Alameda, CA (US); Nancy Keir, Pleasanton, CA (US); and Subam Basuthkar Sundar Rao, San Ramon, CA (US)
Assigned to COOPERVISION INTERNATIONAL LIMITED, Fareham (GB)
Appl. No. 18/837,611
Filed by CooperVision International Limited, Fareham (GB)
PCT Filed Oct. 30, 2023, PCT No. PCT/GB2023/052823
§ 371(c)(1), (2) Date Aug. 12, 2024,
PCT Pub. No. WO2024/094974, PCT Pub. Date May 10, 2024.
Claims priority of provisional application 63/420,738, filed on Oct. 31, 2022.
Int. Cl. G02C 7/04 (2006.01); A45C 11/00 (2006.01); A61F 9/00 (2006.01)
CPC G02C 7/04 (2013.01) [A45C 11/005 (2013.01); A61F 9/0017 (2013.01)] 14 Claims
OG exemplary drawing
 
1. An unworn sterile silicone hydrogel contact lens immersed in a packaging solution and sealed in a package, said contact lens comprising:
(a) a polymeric lens body; and
(b) an amount of WS12 releasably adhered to the polymeric lens body, wherein, the amount of WS12 releasably adhered to the polymeric lens body provides a basal tear concentration in lens wearers of 2 ng/ml to 8 ng/ml WS12 after 30 minutes of lens wear.